PI
MYGN icon

Placemark Investments’s Myriad Genetics MYGN Stock Holding History

Placemark Investments’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-5,324
Closed -$206K – 1673
2014
Q3 		$206K Sell
5,324
-1,822
-25% -$68K ﹤0.01% 1559
2014
Q2 		$278K Sell
7,146
-101
-1% -$3.76K 0.01% 1432
2014
Q1 		$246K Buy
+7,247
New +$225K ﹤0.01% 1419

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 16.21% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Placemark Investments's MYGN Position: Q4 2014 in Review

Placemark Investments sold out of Myriad Genetics (MYGN) in Q4 2014, closing a stake of 5,324 shares — an estimated $206K sold.

Placemark Investments first reported a position in MYGN in Q1 2014 and held it in 3 quarters. The position peaked at $278K in Q2 2014. 273 funds tracked by Wall St. Rank hold MYGN as of Q4 2014.

  • Placemark Investments reported no remaining Myriad Genetics position as of Q4 2014 after selling out during the quarter.
  • Placemark Investments sold 5,324 Myriad Genetics shares in Q4 2014, an estimated $206K.
  • Placemark Investments first reported a position in Myriad Genetics in Q1 2014 and held it in 3 quarters.
  • Placemark Investments's Myriad Genetics position peaked at $278K in Q2 2014.
  • 273 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.